<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Warsaw_Project_theory"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu"><UL><LI class="selected"><A href="/Team:Warsaw/Project/theory">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Warsaw/Project/theory&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Warsaw/Project/theory&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Warsaw/Project/theory&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Warsaw/Project/theory" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Warsaw/Project/theory</H1><DIV id="bodyContent"><H3 id="siteSub">From 2009.igem.org</H3><DIV id="war_menu"><DIV class="war_menu_frame"><OL><LI class="main"><A href="/Team:Warsaw" title="Team:Warsaw">Home page</A></LI><P><LI class="main" onclick="switchMenu('team_submenu','menu_item')"><A name="team" style="cursor: hand; cursor: pointer;">The Team</A></LI></P><DIV id="team_submenu" style="display: none;"><LI class="sub"><A href="/Team:Warsaw/Team" title="Team:Warsaw/Team">About us</A></LI><LI class="sub"><A href="/Team:Warsaw/Team/Supervisors" title="Team:Warsaw/Team/Supervisors">Supervisors</A></LI><LI class="sub"><A href="/Team:Warsaw/Team/Miecznikowa" title="Team:Warsaw/Team/Miecznikowa">The M. Group</A></LI><LI class="sub"><A href="/Team:Warsaw/Team/Pawinskiego" title="Team:Warsaw/Team/Pawinskiego">The P. Group</A></LI></DIV><P><LI class="main" onclick="switchMenu('project_submenu')"><A name="project" style="cursor: hand; cursor: pointer;">The Project</A></LI></P><DIV id="project_submenu" style="display: block;"><LI class="sub"><A href="/Team:Warsaw/Project/introduction" title="Team:Warsaw/Project/introduction">Introduction</A></LI><LI class="sub"><A href="/Team:Warsaw/Project/invasion" title="Team:Warsaw/Project/invasion">Invasiveness</A></LI><LI class="sub"><A href="/Team:Warsaw/Project/endosome" title="Team:Warsaw/Project/endosome">Endosome Module</A></LI><LI class="sub"><A href="/Team:Warsaw/Project/cytoplasm" title="Team:Warsaw/Project/cytoplasm">Cytoplasmatic Module</A></LI><LI class="sub"><A href="/Team:Warsaw/Project/future" title="Team:Warsaw/Project/future">Future plans</A></LI><LI class="sub"><A href="/Team:Warsaw/Bibliography" title="Team:Warsaw/Bibliography">Bibliography</A></LI></DIV><LI class="main"><A href="/Team:Warsaw/results" title="Team:Warsaw/results">Results</A></LI><LI class="main" onclick="switchMenu('modelling_submenu')"><A name="modelling" style="cursor: hand; cursor: pointer;">Modelling</A></LI><DIV id="modelling_submenu" style="display: none"><LI class="sub"><A href="/Team:Warsaw/Modelling" title="Team:Warsaw/Modelling">System Overview</A></LI><LI class="sub"><A href="/Team:Warsaw/Modelling/Apoptosis" title="Team:Warsaw/Modelling/Apoptosis">Apoptosis</A></LI><LI class="sub"><A href="/Team:Warsaw/Modelling/Structural" title="Team:Warsaw/Modelling/Structural">Structural</A></LI><LI class="sub"><A href="/Team:Warsaw/Modelling/Gene_Networks" title="Team:Warsaw/Modelling/Gene Networks">Gene Networks</A></LI><LI class="sub"><A href="/Team:Warsaw/Modelling/Invasiveness" title="Team:Warsaw/Modelling/Invasiveness">Invasiveness</A></LI></DIV><P><LI class="main" onclick="switchMenu('lab_submenu')"><A name="lab" style="cursor: hand; cursor: pointer;">Lab Work</A></LI></P><DIV id="lab_submenu" style="display: none"><LI class="sub"><A href="/Team:Warsaw/Notebook" title="Team:Warsaw/Notebook">Notebook</A></LI><LI class="sub"><A href="/Team:Warsaw/protocols" title="Team:Warsaw/protocols">Protocols</A></LI><LI class="sub"><A href="/Team:Warsaw/Resources" title="Team:Warsaw/Resources">Resources</A></LI></DIV><LI class="main"><A href="/Team:Warsaw/Parts" title="Team:Warsaw/Parts">Submitted Parts</A></LI><LI class="main"><A href="/Team:Warsaw/Glossary" title="Team:Warsaw/Glossary">Glossary</A></LI><LI class="main"><A href="/Team:Warsaw/Biosafety" title="Team:Warsaw/Biosafety">Biosafety</A></LI><LI class="main"><A href="/Team:Warsaw/Human" title="Team:Warsaw/Human">Human Practices</A></LI><LI class="main"><A href="/Team:Warsaw/Acknowledgements" title="Team:Warsaw/Acknowledgements">Acknowledgements</A></LI></OL></DIV><DIV class="war_menu_frame_bottom"> </DIV></DIV><DIV id="war_content"><H2><SPAN class="mw-headline" id="Theoretical_basis">Theoretical basis</SPAN></H2><TABLE id="toc" class="toc"><TBODY><TR><TD><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Theoretical_basis"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Theoretical basis</SPAN></A></LI><LI class="toclevel-2 tocsection-2"><A href="#Introduction"><SPAN class="tocnumber">1.1</SPAN><SPAN class="toctext">Introduction</SPAN></A></LI><LI class="toclevel-2 tocsection-3"><A href="#Entrance_of_bacteria_into_eukaryotic_cells"><SPAN class="tocnumber">1.2</SPAN><SPAN class="toctext">Entrance of bacteria into eukaryotic cells</SPAN></A></LI><LI class="toclevel-2 tocsection-4"><A href="#Escape_from_the_phagosome"><SPAN class="tocnumber">1.3</SPAN><SPAN class="toctext">Escape from the phagosome</SPAN></A></LI><LI class="toclevel-2 tocsection-5"><A href="#Mitochondrial_transformation"><SPAN class="tocnumber">1.4</SPAN><SPAN class="toctext">Mitochondrial transformation</SPAN></A></LI><LI class="toclevel-2 tocsection-6"><A href="#Bacterial_systems_of_protein_secretion"><SPAN class="tocnumber">1.5</SPAN><SPAN class="toctext">Bacterial systems of protein secretion</SPAN></A></LI><LI class="toclevel-2 tocsection-7"><A href="#Induction_of_apoptosis_by_p53"><SPAN class="tocnumber">1.6</SPAN><SPAN class="toctext">Induction of apoptosis by p53</SPAN></A></LI></UL></TD></TR></TBODY></TABLE><H3><SPAN class="mw-headline" id="Introduction">Introduction</SPAN></H3><P>We have decided to use already existing systems responsible for virulency and invasiveness of different enteropathogenic bacteria, like <I>Listeria</I> sp., <I>Yersinia</I> sp. or <I>Salmonella</I> sp. We will also use some mammalian proteins responsible for induction of <A href="https://2009.igem.org/Team:Warsaw/Glossary#apoptosis" class="external text" rel="nofollow">apoptosis</A>. 
Below some basic ideas are introduced to make the understanding of the whole project simpler.
</P><H3><SPAN class="mw-headline" id="Entrance_of_bacteria_into_eukaryotic_cells">Entrance of bacteria into eukaryotic cells</SPAN></H3><P>Many bacterial species are capable of entering mammalian cells. One of the crucial proteins for this process is <A href="https://2009.igem.org/Team:Warsaw/Glossary#invasin" class="external text" rel="nofollow">invasin</A>. It is capable of selective interaction with <A href="https://2009.igem.org/Team:Warsaw/Glossary#integrins" class="external text" rel="nofollow">integrins</A>, which are present on external eukaryotic membrane. This triggers signalling cascade, indispensable to start endocytosis [9]. This interaction occurs via the <A href="https://2009.igem.org/Team:Warsaw/Glossary#invasin" class="external text" rel="nofollow">invasin</A> N-terminal domain, which is capable of promoting effective endocytosis of bacteria that synthesize <A href="https://2009.igem.org/Team:Warsaw/Glossary#invasin" class="external text" rel="nofollow">invasin</A> by cells normally unable to undertake phagocytosis [3]. The other protein which is involved in process of entering mammalian cells is <A href="https://2009.igem.org/Team:Warsaw/Glossary#internalin" class="external text" rel="nofollow">internalin</A>, which can be found on the surface of <I>Listeria monocytogenes</I>. <A href="https://2009.igem.org/Team:Warsaw/Glossary#internalin" class="external text" rel="nofollow">Internalin</A> is selecively interacting with cadherins found on the external eukaryotic membrane.
</P><H3><SPAN class="mw-headline" id="Escape_from_the_phagosome">Escape from the phagosome</SPAN></H3><P>Although the induction of phagocytosis and entrance into the eukaryotic cell seems to be simple, this is not the final step of bacteria invasion. Majority of the enteropathogenic bacteria are incapable of dividing within the <A href="https://2009.igem.org/Team:Warsaw/Glossary#endosome" class="external text" rel="nofollow">phagosome</A>, but subsequently to leaving the <A href="https://2009.igem.org/Team:Warsaw/Glossary#endosome" class="external text" rel="nofollow">phagosome</A> they can proliferate rapidly within the cytoplasm. Escape from the <A href="https://2009.igem.org/Team:Warsaw/Glossary#endosome" class="external text" rel="nofollow">phagosome</A> is possible due to <A href="https://2009.igem.org/Team:Warsaw/Glossary#listeriolysin" class="external text" rel="nofollow">hemolysin</A>, which causes membrane permeabilisation and <A href="https://2009.igem.org/Team:Warsaw/Glossary#endosome" class="external text" rel="nofollow">phagosome</A> disruption [16]. It was previously demonstrated that transfection with hemolysin-encoding gene is sufficient for enabling the escape from phagosomal vesicle of both <I>Bacillus subtilis</I> and <I>Escherichia coli</I>[1]. 
Process of escape from the phagosome is usually strictly regulated. Interesting example is the <A href="https://2009.igem.org/Team:Warsaw/Glossary#phoP.2FPhoQ" class="external text" rel="nofollow">PhoP/PhoQ regulon</A>, existing for example in <I>Salmonella enterica</I> ser. <I>typhimurium</I> LT2. It's a two-component regulatory system which reply to intramacrophage conditions like low pH or low metal ions concentration, leading to activation of PhoP-dependent genes, responsible for virulence of bacteria, like the <A href="https://2009.igem.org/Team:Warsaw/Glossary#mgtc_gene_promoter" class="external text" rel="nofollow">MgtC</A> gene.
</P><H3><SPAN class="mw-headline" id="Mitochondrial_transformation">Mitochondrial transformation</SPAN></H3><P>Electron transport chain functioning can be impaired by a variety of defects on the DNA level: not only point mutation and local deletions in genes encoding proteins of the chain, but also deletions of larger fragments or even of the whole mitochondrial genome (mtDNA). Correct mitochondrion contains 2 to 10 copies of mtDNA. Defects in mitochondrial DNA result in severe medical disorders especially in tissues which require large amounts of energy (such as nervous and muscle tissue). Effects of this impairments are neuro and myopathies [20]. The standard therapy based on bypassing interrupted pathways does not apply under these circumstances. Administration of enzyme cofactors and other metabolically active substances is not effective and may be applied only as supplementary therapy. We are forced to seek novel treatment strategies to cure patients suffering from mitochondrial disorders [7]. Currently the most commonly used method of mitochondrial transformation is the &quot;gene gun&quot; approach which is based on delivery of metal beads coated with DNA into the cell. This method is mostly limited to plants and fungi and has low therapeutic potential [7]. Current mammalian mitochondrial transformation techniques like electroporation also have serious limitations. Whole process takes place ex vivo and causes irreversible damage to the mitochondrion which make its efficient reintroduction into the cell almost impossible. The conjugation between bacteria and mitochondria is free from these side effects. Moreover, this phenomenon has been preformed in vitro.[22]. More recently a conjugation between two strains of bacteria within the cytoplasm of a mammalian cell has been observed . These findings suggest that conjugation between a bacterium and a mitochondrion is feasible [10].
</P><H3><SPAN class="mw-headline" id="Bacterial_systems_of_protein_secretion">Bacterial systems of protein secretion</SPAN></H3><P>Free living bacteria make use of diverse transport and secretion systems. In gram negative bacteria <A href="https://2009.igem.org/Team:Warsaw/Glossary#Type_I_secretion_system" class="external text" rel="nofollow">type I secretion systems</A> are very common e.g. the well characterized <A href="https://2009.igem.org/Team:Warsaw/Glossary#listeriolysin" class="external text" rel="nofollow">hemolysin</A> secretion system. <A href="https://2009.igem.org/Team:Warsaw/Glossary#listeriolysin" class="external text" rel="nofollow">hemolysin</A> is responsible for pathogenicity of some <I>E. coli</I> strains. Obtaining a fusion of protein of interest with <A href="https://2009.igem.org/Team:Warsaw/Glossary#listeriolysin" class="external text" rel="nofollow">hemolysin</A> C-terminus results in secretion of the protein into the growth medium[6] The same method can be used to secret bacterial proteins into the cytoplasm. This has already found its application in the new generation of vaccines[5].
</P><H3><SPAN class="mw-headline" id="Induction_of_apoptosis_by_p53">Induction of <A href="https://2009.igem.org/Team:Warsaw/Glossary#apoptosis" class="external text" rel="nofollow">apoptosis</A> by <A href="https://2009.igem.org/Team:Warsaw/Glossary#p53" class="external text" rel="nofollow">p53</A></SPAN></H3><P>Mitochondrial outer membrane permabilization MOMP is one of the main programmed cell death mechanisms. The process is regulated by PTPc complex and Bcl2 family proteins [17]. Many cancer types involve disruption of this process therefore inducing MOMP in the tumour cells is regarded as potential therapeutic solution. MOMP-inducing factors include the <A href="https://2009.igem.org/Team:Warsaw/Glossary#p53" class="external text" rel="nofollow">p53</A> protein, which is mutated in almost half of the cancer cases. . By acting as a transcription regulator in the nucleus, <A href="https://2009.igem.org/Team:Warsaw/Glossary#p53" class="external text" rel="nofollow">p53</A> arrests the cell cycle and induce <A href="https://2009.igem.org/Team:Warsaw/Glossary#apoptosis" class="external text" rel="nofollow">apoptosis</A> [18]. In the cytoplasm <A href="https://2009.igem.org/Team:Warsaw/Glossary#p53" class="external text" rel="nofollow">p53</A> interacts with mitochondrial membrane and can enter the mitochondrion. It has been proven that these processes induce <A href="https://2009.igem.org/Team:Warsaw/Glossary#apoptosis" class="external text" rel="nofollow">apoptosis</A> and does not influence the cell cycle. In the mitochondrion <A href="https://2009.igem.org/Team:Warsaw/Glossary#p53" class="external text" rel="nofollow">p53</A> is an effector protein that activates soluble (cytochrom c, Smac) and insoluble (AIF, EndoG) apoptototic factors. Moreover interaction of <A href="https://2009.igem.org/Team:Warsaw/Glossary#p53" class="external text" rel="nofollow">p53</A> and Bax protein in vitro leads to permabilisation of lipid bilayer analogous to mitochondrial membrane. [12] Because <A href="https://2009.igem.org/Team:Warsaw/Glossary#p53" class="external text" rel="nofollow">p53</A> is inactive in tumour cells many research groups focused on designing gene therapies based on <A href="https://2009.igem.org/Team:Warsaw/Glossary#p53" class="external text" rel="nofollow">p53</A> gene delivery. Most frequently adenoviruses and eukaryotic plasmids were used. The results confirmed increased effectiveness of chemotherapeutic drugs following introduction of <A href="https://2009.igem.org/Team:Warsaw/Glossary#p53" class="external text" rel="nofollow">p53</A> gene copy into the cell [4]. It has been shown that <A href="https://2009.igem.org/Team:Warsaw/Glossary#p53" class="external text" rel="nofollow">p53</A> with the mitochondrial leader sequence alone is sufficient to induce <A href="https://2009.igem.org/Team:Warsaw/Glossary#apoptosis" class="external text" rel="nofollow">apoptosis</A> in mammalian cells. Fusion protein Lp53, with mitochondrial leader sequence from ornithine transcarbamylase was used. In terms of <A href="https://2009.igem.org/Team:Warsaw/Glossary#apoptosis" class="external text" rel="nofollow">apoptosis</A> induction fusion protein was almost as effective as standard <A href="https://2009.igem.org/Team:Warsaw/Glossary#p53" class="external text" rel="nofollow">p53</A>. Previous research did not include delivery of <A href="https://2009.igem.org/Team:Warsaw/Glossary#p53" class="external text" rel="nofollow">p53</A> into tumour cells by bacterial vectors. Our project proposes a method to induce apoptosis without arresting the cell cycle. Cell cycle arrest decreases the sensitivity of cancer cells to chemotherapeutic agents, because they can affect only proliferating cells [14].
</P><DIV id="footer-div" style="display: none;">

(C) iGEM 2009 Warsaw Team
</DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2009.igem.org/Team:Warsaw/Project/theory">http://2009.igem.org/Team:Warsaw/Project/theory</A>&quot;</DIV></DIV></DIV><DIV id="footer-box"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Warsaw/Project/theory" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Warsaw/Project/theory" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Warsaw/Project/theory&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Warsaw/Project/theory&amp;oldid=109935" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2009.igem.org:Privacy_policy" title="2009.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2009.igem.org:General_disclaimer" title="2009.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>